Detalhe da pesquisa
1.
Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer.
Breast Cancer Res
; 25(1): 138, 2023 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37946201
2.
18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study.
Breast Cancer Res
; 23(1): 88, 2021 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34425871
3.
Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancer.
Eur J Nucl Med Mol Imaging
; 48(12): 3990-4001, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33677641
4.
Correction to: Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancer.
Eur J Nucl Med Mol Imaging
; 48(12): 4109, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117509
5.
Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer: 18F-Fluoroestradiol PET Imaging Shows Return of ER Expression.
J Natl Compr Canc Netw
; 14(2): 144-7, 2016 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26850484
6.
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials.
EJNMMI Res
; 14(1): 32, 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38536511
7.
Repeatability of 18F-FDG uptake in metastatic bone lesions of breast cancer patients and implications for accrual to clinical trials.
Res Sq
; 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38313279
8.
Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-18F-Fluoro-17ß-Fluoroestradiol.
J Nucl Med
; 64(3): 351-354, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36863779
9.
18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast Cancer.
J Nucl Med
; 62(2): 184-190, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32591490
10.
Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17ß-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC).
Mol Imaging Biol
; 21(1): 191, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30324461
11.
Test-Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network.
J Nucl Med
; 60(5): 608-614, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30361381
12.
Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol.
J Nucl Med
; 49(3): 367-74, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18287268
13.
Clinical Potential of Estrogen and Progesterone Receptor Imaging.
PET Clin
; 13(3): 415-422, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30100079
14.
Prospective Study of Serial 18F-FDG PET and 18F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer.
J Nucl Med
; 59(12): 1823-1830, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748233
15.
Dynamic and static approaches to quantifying 18F-FDG uptake for measuring cancer response to therapy, including the effect of granulocyte CSF.
J Nucl Med
; 48(6): 920-5, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17504870
16.
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer.
Clin Cancer Res
; 12(18): 5435-41, 2006 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17000677
17.
Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer.
Clin Cancer Res
; 23(2): 407-415, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27342400
18.
A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapy.
Phys Med Biol
; 62(9): 3639-3655, 2017 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28191877
19.
Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size.
J Nucl Med
; 57(2): 226-30, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26493206
20.
In vivo validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors.
Clin Cancer Res
; 8(11): 3315-23, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12429617